Press Releases | DEA.gov
Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
      • Domestic Divisions
      • Foreign Divisions
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • What We Do
    • Forensic Sciences
      • GUARDS
      • Forensic Sciences Policy
      • Forensic Science Organizations
      • Forensic Science Contact
    • Law Enforcement
      • DEA Office of Training
        • Office of Training Programs
      • El Paso Intelligence Center (EPIC)
      • Intelligence
      • Operations
        • Administrative Law Judges
        • DEA Asset Forfeiture
        • Domestic Cannabis Suppression / Eradication Program
        • HIDTA
        • OCDETF
    • Education and Prevention
      • Family Summit
      • Red Ribbon
      • Kiki and the History of Red Ribbon Week
      • Red Ribbon Toolkit - Resources For Your Community
      • DEA’s Family Summit
      • Operation Engage
      • Community Outreach
      • Just Think Twice
      • Campus Drug Prevention
      • Get Smart About Drugs
      • Operation Prevention
    • Drug Information
      • Drug Policy
      • Drug Scheduling
      • The Controlled Substances Act
    • News
      • Alerts
      • Press Releases
      • Most Wanted Fugitives
        • All Fugitives
      • Stories
      • Events
      • Speeches
      • Testimony
    • Campaigns
      • One Pill Can Kill
        • Senior Citizens
        • Partner Toolbox
        • Social Media Campaign
      • DEA National Prescription Drug Take Back Day
  • Careers
    • Special Agent
      • Special Agent FAQs
    • Diversion Investigator
      • Diversion Investigator Job Announcement
    • Intelligence Research Specialist
      • Intelligence Research Specialist Job Announcements
      • Intelligence Research Specialists FAQs
      • Schedule A Hiring Authority: Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
      • How To Claim Veterans' Preference
      • Priority Consideration
      • Benefits
      • Veterans and People With Disabilities
      • Operation Warfighter
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
      • Domestic Arrests
      • Staffing and Budget
    • FOIA
      • About FOIA
      • Contact DEA FOIA
      • Make a Request
      • What Happens After Making a Request
      • Requester Categories
      • Fees Charged
      • Fee Waiver
      • FOIA FAQ
      • FOIA Logs and Reports
      • FOIA Library
      • Additional FOIA Links
      • FOIA Exemptions
      • What Are Exclusions?
      • Privacy Act
      • Privacy Act Exemptions
      • Privacy Impact Assessment and Management Information Systems
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
      • Victim Witness Assistance Program Resources
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Get Updates
  • Scam Alert
  • Full Menu
  • English
  • Español

Main Menu

Explore DEA
  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Education and Prevention
    • Drug Information
    • News
    • Campaigns
  • Careers
    • Special Agent
    • Diversion Investigator
    • Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
    • FOIA
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
  • Submit A Tip

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2026 (13)
  • 2025 (73)
  • 2024 (73)
  • 2023 (93)
  • 2022 (102)
  • 2021 (64)
  • 2020 (11)
  • 2019 (3)
  • 2018 (1)
  • 2017 (1)

Subject

  • Drug Trafficking (4210)
  • Synthetic drugs (1141)
  • Guns/Weapons (1041)
  • OCDETF/Task Force (820)
  • Fake Pills (688)
  • Arrests/Convictions - Major (646)
  • Guilty Plea (559)
  • Seizures (Drugs/Property) (484)
  • Prescription Drugs (372)
  • Overdose (327)
  • Major Law Enforcement Operation (278)
  • Take Back Day (246)
  • Task Forces/Task Force Officers (239)
  • Pharmaceuticals/Pharmacists/Physicians (228)
  • Money Laundering (218)
  • Gangs (202)
  • Fentanyl Awareness (167)
  • One Pill Can Kill (118)
  • HIDTA (105)
  • Press Conferences (69)
  • Narcoterrorism (55)
  • Prevention/Education - DEA websites GSAD, JTT etc (54)
  • Extraditions (52)
  • Public and Media Affairs - also see Congressional Affairs (51)
  • Fentanyl Free America (41)
  • Counterfeit Pills (39)
  • Asset Forfeiture (30)
  • Dark Web- Internet Trafficking (29)
  • International/Foreign Operations (28)
  • Red Ribbon (27)
  • Congressional Affairs (15)
  • Campaigns (14)
  • Terrorism (14)
  • Other (12)
  • Critical Incident (9)
  • Intergovernmental Affairs (9)
  • Cartel (6)
  • Intelligence Division - Intelligence Products (5)
  • Scam Calls (5)
  • Museum and Visitors Center (3)
  • El Paso Intelligence Center (2)
  • Recruitment/Office of Training/Graduations (2)
  • Diversion Division (254)
  • Outreach/Drug Prevention (189)

Drug Name

  • Fentanyl (88)
  • Opioids (58)
  • Oxycodone (39)
  • Synthetic Opioids (25)
  • Methamphetamine (20)
  • Hydromorphone (16)
  • Benzodiazepines (11)
  • Cocaine (7)
  • Morphine (7)
  • Amphetamines (6)
  • Marijuana (Cannabis) (5)
  • Heroin (3)
  • Methadone (3)
  • Steroids (3)
  • Ketamine (1)
  • Marijuana Concentrates (1)

Field Division

  • Washington, DC (56)
  • New England (38)
  • Omaha (37)
  • Seattle (36)
  • Headquarters (33)
  • New York (26)
  • Chicago (20)
  • El Paso (20)
  • Houston (18)
  • St. Louis (18)
  • Miami (17)
  • New Jersey (16)
  • New Orleans (16)
  • Atlanta (15)
  • Rocky Mountain (14)
  • Phoenix (11)
  • San Francisco (9)
  • San Diego (8)
  • Dallas (7)
  • Los Angeles (7)
  • Detroit (6)
  • Louisville (3)
  • Philadelphia (3)
Clear All Results
434 Results - Showing 291 to 300
PRESS RELEASE

Nurse Arrested for Diversion of Controlled Substances

BRADFORD, Vt. - Amy J. Vickers, 44, of Bradford, Vermont was arrested today on a complaint charging her with obtaining controlled substances by misrepresentation, fraud, forgery, deception or subterfuge, U.S. Attorney Jane E. Young announced. According to the complaint, on June 17, 2022, Vickers was working as a nurse at...
PRESS RELEASE

New Jersey Pharmacy Admits Illegal Distribution of Prescription Opioids and Kickback Scheme

NEWARK, N.J. – Susan A. Gibson, Special Agent in Charge of the Drug Enforcement Administration’s New Jersey Division, Scott J. Lampert, Special Agent in Charge of the U.S. Department of Health and Human Services, Office of Inspector General, Office of Investigations-New Jersey Field Office, Patrick J. Hegarty, Defense Criminal Investigative...
PRESS RELEASE

DEA Reminds Families to Discuss the Dangers of Drugs Before Students Return to School

OMAHA, Neb. – As students across Nebraska prepare for a return to school, the Drug Enforcement Administration (DEA) Omaha Division encourages families to make time for conversations about the dangers of drug use and consequences of experimentation. Methamphetamine and fake pill seizures remain high in Nebraska and the DEA wants...
PRESS RELEASE

Former Nurse Sentenced to 18 Months in Federal Prison for Tampering with Morphine Medications at Moses Lake Clinic

SPOKANE, Wash. – Vanessa R. Waldref, the United States Attorney for the Eastern District of Washington, announced today that Esther Rae Tuller, age 41, of Moses Lake, Washington, was sentenced today in federal court in Spokane for tampering with morphine medication while working as a registered nurse. Chief United States...
PRESS RELEASE

DEA Graduates the Sixth Annual Citizens Academy Class in Richmond, Virginia

Richmond, Va., – The United States Drug Enforcement Administration is active in many local communities through Operation Engage, a comprehensive community-level approach to address the drug epidemic through prevention strategies, facilitating conversations, and collaboration with local partners. As part of this mission, Citizens Academies are held to connect field offices...
PRESS RELEASE

Justice Department Obtains Temporary Restraining Order to Prevent Tampa-Area Physician from Writing Opioid Prescriptions

WASHINGTON – A federal court issued a temporary restraining order prohibiting a Tampa-area physician from prescribing opioids and other controlled substances, the Department of Justice announced today. In a complaint filed on July 18, and unsealed yesterday, the United States alleges that Dr. Neelam Taneja Uppal unlawfully wrote opioid prescriptions...
PRESS RELEASE

DEA Omaha Division Special Agent in Charge Speaks with School Administrators about the Drug Threat Facing Nebraska

KEARNEY, Neb. – Drug Enforcement Administration (DEA) Omaha Division Special Agent in Charge Justin King addressed members of the Nebraska Council of School Administrators (NCSA) today at the Younes Conference Center in Kearney discussing national and statewide drug trends and their impact on Nebraska’s communities. “Overdose deaths are at an...
PRESS RELEASE

Minnesota Pharmacist Pleads Guilty to Misappropriating and Adulterating Prescription Pain Medication

MINNEAPOLIS – A Minneapolis woman has pleaded guilty to misappropriating and adulterating prescription morphine while working as a pharmacist. According to court documents, on October 30, 2019, Jennifer Lee Draheim, 42, a pharmacist at Coburn’s Pharmacy in Ramsey, removed a bottle of morphine sulfate from the Scheduled Drug Cabinet and...
PRESS RELEASE

Oklahoma City Hospital Pays $120,000 to Settle Civil Penalty Claims

OKLAHOMA CITY, OK – INTEGRIS ProHealth, Inc., and its parent, INTEGRIS Health, Inc. (collectively, “INTEGRIS”) paid $120,000 to settle civil penalty claims stemming from allegations that Integris Baptist Medical Center Pharmacy (“Integris Pharmacy”), which is owned and operated by INTEGRIS ProHealth, Inc., violated the Comprehensive Drug Abuse Prevention and Control...
PRESS RELEASE

Two Day Stretch in Omaha Nets 32,000 Fake Fentanyl Pills

OMAHA, Neb.–Investigators with the Drug Enforcement Administration (DEA) Omaha Division seized approximately 32,000 fake pills in Omaha, some laced with lethal doses of fentanyl, in a two-day span beginning July 8. During the first six months of 2022, DEA investigators seized approximately 151,500 pills in Nebraska, marking an 83 percent...

Pagination

  • First page «
  • Previous
  • Page 26
  • Page 27
  • Page 28
  • Page 29
  • Current page 30
  • Page 31
  • Page 32
  • Page 33
  • Page 34
  • Next
  • Last page »
  • Who We Are
    • About
    • Domestic Divisions
    • Foreign Offices
    • Contact Us
    • DEA Museum
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Drug Prevention
    • Diversion Control Division
    • News
  • Careers
    • Special Agent
    • Diversion Investigator
    • Forensic Sciences
    • Intelligence Research Specialist
    • How to Apply
  • Resources
    • Drug Information
    • Employee Assistance Program
    • FOIA
    • Publications
    • Media Galleries
    • VWAP
  • Doing Business
    with the DEA
    • Overview
    • Current Vendors
    • Prospective Vendors
    • Security Clauses
    • Security Forms
    • Small Business Program
    • Vendor Engagement Request
  • Policies
    • Accessibility & Policy
    • Legal Policies & Disclaimers
    • No FEAR Act
    • Privacy Policy
    • U.S. Department of Justice EEO Policy
    • USA.gov
    • Whistleblower Protection
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster